Search results
Results From The WOW.Com Content Network
American chemist Linus Pauling coined the term "orthomolecular" in the 1960s to mean "the right molecules in the right amounts" (ortho-in Greek implies "correct"). [11] Proponents of orthomolecular medicine hold that treatment must be based on each patient's individual biochemistry. [12] [13]
The major shortcoming of most patient portals is their linkage to a single health organization. If a patient uses more than one organization for healthcare, the patient normally needs to log on to each organization's portal to access information. This results in a fragmented view of individual patient data.
Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions: Ortho-McNeil, based in Raritan, NJ (United States); the division is focused on primary care. [1] Janssen, based in Beerse (Belgium); formerly Janssen Pharmaceutica; the division is focused on mental health. [2]
The Journal of Orthomolecular Medicine is not indexed by MEDLINE, a database of biomedical literature.Journals are selected for MEDLINE by the National Library of Medicine based on scope and coverage, quality of content, quality of editorial work, intended audience, quality of the layout, printing, graphics, and illustrations. [6]
Upgrade to a faster, more secure version of a supported browser. It's free and it only takes a few moments:
[2] [3] Orthomolecular psychiatry's goal of weaning patients from conventional neuroleptic drugs [4] follows "Pfeiffer's Law", "For every drug that benefits a patient, there is a natural substance that can achieve the same effect". [5] In 1968, Linus Pauling first used the term orthomolecular. [6] [7]
Ortho Clinical Diagnostics (now QuidelOrtho) is an in vitro diagnostics company that made products and diagnostic equipment for blood testing.Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion ...
AMP seeks to shape and promote policies that ensure broad and equitable patient access to appropriate laboratory testing. Internationally, AMP members are involved in advocating for appropriate molecular diagnostic testing in several countries around the world. [8] Association for Molecular Pathology v. Myriad Genetics, Inc.